WordNet

a contraceptive in the form of a pill containing estrogen and progestin to inhibit ovulation and so prevent conception (同)birth_control_pill, contraceptive pill, oral_contraceptive_pill, oral_contraceptive, anovulatory drug, anovulant
a dose of medicine in the form of a small pellet (同)lozenge, tablet, tab
something that resembles a tablet of medicine in shape or size
a unpleasant or tiresome person
something unpleasant or offensive that must be tolerated or endured; "his competitors success was a bitter pill to take"
of or relating to or affecting or for use in the mouth; "oral hygiene"; "an oral thermometer"; "an oral vaccine"
an examination conducted by spoken communication (同)oral exam, oral_examination, viva voce, viva
using speech rather than writing; "an oral tradition"; "an oral agreement" (同)unwritten
a stage in psychosexual development when the childs interest is concentrated in the mouth; fixation at this stage is said to result in dependence, selfishness, and aggression
of or involving the mouth or mouth region or the surface on which the mouth is located; "the oral cavity"; "the oral mucous membrane"; "the oral surface of a starfish"
capable of preventing conception or impregnation; "contraceptive devices and medications" (同)prophylactic, antifertility
an agent or device intended to prevent conception (同)preventive, preventative, contraceptive_device, prophylactic device, birth control device
the ratio of the circumference to the diameter of a circle; approximately equal to 3.14159265358979323846...
the 16th letter of the Greek alphabet

PrepTutorEJDIC

『丸薬』;《the pill》《話》ピル(経口避妊薬) / (耐えなければならない)不快なこと,苦しいこと / 《通例単数形で》《俗》いやなやつ
『口頭の』,口述の(spoken) / 口の,口部の / 経口の
避妊薬;避妊用具 / 避妊[用]の
〈C〉パイ(ギリシア語アルファベットの第16字Π,π;英語のP,pに相当) / 〈U〉円周率(記号はπ)
ごちゃまぜの活字 / ごちゃまぜ,混乱
《選択を表し,語句・節を結んで》《肯定文・疑問文で》・・・『または』・・・,・・・か・・・ / 《否定文で》・・・も・・・もない / 《命令的表現の後で》『さもないと』 / 《前出の語を言い換えたり説明したりして》『すなわち』,言い換えれば

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2014/12/28 16:12:52」(JST)

wiki en

[Wiki en表示]

Oral contraceptives, abbreviated OCPs, also known as birth control pills are medications taken by mouth for the purpose of birth control.

Female

Two types of female oral contraceptive pill, taken once per day, are widely available:

The combined oral contraceptive pill contains estrogen and progestin
The progestin-only pill

Emergency contraception pills ("morning after pills") are taken at the time of intercourse, or within a few days afterwards.

Yuzpe regimen uses combined oral contraceptives
Ulipristal acetate is an antiprogestogen

Other types of female oral contraceptive are experimental or only available in limited areas:

Mifepristone is an antiprogestogen which has been used as a daily oral contraceptive in investigational clinical trials.
Ormeloxifene (also known as Centchroman) is a selective estrogen receptor modulator which is taken one to two times per week. Ormeloxifene is approved as an oral contraceptive only in India.^{[citation needed]}

Male

Male oral contraceptives are currently not available commercially, although several possibilities are in various stages of research and development

This article includes a list of related items that share the same name (or similar names).
If an internal link incorrectly led you here, you may wish to change the link to point directly to the intended article.

References

External links

http://www.plannedparenthood.org/health-topics/birth-control/birth-control-pill-4228.htm
http://www.patient.co.uk/health/combined-oral-contraceptive-pill

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. エストロゲン・プロゲスチン避妊剤の使用に関する概要 overview of the use of estrogen progestin contraceptives
2. エストロゲン・プロゲスチン避妊剤と関連したリスクおよび副作用 risks and side effects associated with estrogen progestin contraceptives
3. 避妊の概要 overview of contraception
4. 避妊：思春期に固有の問題の概要 contraception overview of issues specific to adolescents
5. 月経抑制のためのホルモン避妊法 hormonal contraception for suppression of menstruation

English Journal

Prevalence of antenatal depressive symptoms among women in Sabah, Malaysia.

Mohamad Yusuff AS1, Tang L2, Binns CW2, Lee AH2.
The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.J Matern Fetal Neonatal Med.2016 Apr;29(7):1170-4. doi: 10.3109/14767058.2015.1039506. Epub 2015 Jun 3.
OBJECTIVE: To investigate the prevalence of antenatal depression and to assess whether the common risk factors identified in previous studies were applicable to women in Sabah, Malaysia.METHODS: A prospective cohort study of 2072 women was conducted in Sabah during 2009-2010. Participants were recru
PMID 26037724

Association between number of live births and markers of subclinical atherosclerosis: The Dallas Heart Study.

Sanghavi M1, Kulinski J2, Ayers CR3, Nelson D4, Stewart R4, Parikh N5, de Lemos JA3, Khera A3.
European journal of preventive cardiology.Eur J Prev Cardiol.2016 Mar;23(4):391-9. doi: 10.1177/2047487315571891. Epub 2015 Feb 17.
AIMS: Higher parity has been associated with increased maternal risk of cardiovascular disease, but the mechanism is not well delineated. Whether the number of live births is associated with coronary and aortic subclinical atherosclerosis has not been fully evaluated.METHODS AND RESULTS: Women from
PMID 25691547

Evaluation of contraceptive methods in women with congenital heart disease in Germany, Hungary and Japan.

Koerten MA1, Szatmári A2, Niwa K3, Ruzsa Z4, Nagdyman N5, Niggemeyer E6, Peters B7, Schneider KT8, Kuschel B8, Mizuno Y9, Berger F10, Bauer UM11, Kaemmerer H12.
International journal of cardiology.Int J Cardiol.2016 Mar 1;206:13-8. doi: 10.1016/j.ijcard.2015.12.031. Epub 2015 Dec 30.
AIMS: For women with congenital heart defects (CHD), pregnancy may pose a health risk. Sexually active women with CHD without the desire for own children or for whom pregnancy would imply considerable health risks require adequate counselling regarding appropriate contraception. This study gathers d
PMID 26773763